Manufacturer of Controlled Substances; Notice of Registration

Summary

The U.S. Drug Enforcement Administration (DEA) has published a notice of registration for a pharmaceutical company, announcing its intention to manufacture and distribute controlled substances, such as opioids and other prescription medications, in compliance with federal regulations.